- Tytuł:
- Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
- Autorzy:
- Źródło:
- In The Lancet Respiratory Medicine January 2021 9(1):96-106
- Czasopismo naukowe